Papers

CD4+ T cell-mediated immunity protects from VSV-SUD lethal challenge in a mouse model of Sudan virus infection

by Fatih Dikmen
April 2, 2026

Authors: Lara Kelchtermans, Katrien Geerts, Cuong Thi Pham, Vanshika Malviya, Winston Chiu, Carolien De Keyzer, Elias Broeckhoven, Johan Neyts, Susan Schlenner, Yeranddy A. Alpizar & Kai Dallmeier Journal: Nature immunologyPublished: 25 March 2026DOI: https://doi.org/10.1038/s41590-026-02478-7 Abstract Recurring outbreaks… Read More »CD4+ T cell-mediated immunity protects from VSV-SUD lethal challenge in a mouse model of Sudan virus infection

Advancing public health: a roadmap to the implementation of tools required to eliminate HPV-related cancers and diseases in Belgium by 2030

by Fran Van Heuverswyn
March 5, 2026March 9, 2026

About this white paper This white paper is an evidence-based call to action for Belgian policymakers on the implementation of tools required to eliminate HPV-related… Read More »Advancing public health: a roadmap to the implementation of tools required to eliminate HPV-related cancers and diseases in Belgium by 2030

Immunopeptidomics of cutaneous leishmaniasis patients reveals the natural antigenic landscape

by Fran Van Heuverswyn
February 20, 2026March 13, 2026

Authors: Nicky de Vrij, Elise Pepermans, Louise Laurijssen, Thao-Thy Pham, Lauren Thijs, Kurt Boonen, Kadrie Ramadan, Ilse Maes, Yetemwork Aleka, Mekibib Kassa, Tigist Mekonnen, Mezgebu… Read More »Immunopeptidomics of cutaneous leishmaniasis patients reveals the natural antigenic landscape

Durability of the BNT162b2 XBB:1.5-adapted vaccine against JN.1 hospitalisation in Europe, October 2023 to August 2024: A test-negative case-control study using the id.DRIVE platform

by Fran Van Heuverswyn
February 11, 2026March 13, 2026

Hannah R. Volkman , Leonie de Munter, Jennifer L. Nguyen, Thao M. P. Tran, Marianna itratza,Cátia Marques, Laura Choi, Srinivas Valluri, Jingyan Yang, Andrés Antón, Irma… Read More »Durability of the BNT162b2 XBB:1.5-adapted vaccine against JN.1 hospitalisation in Europe, October 2023 to August 2024: A test-negative case-control study using the id.DRIVE platform

Recombinant zoster vaccine is associated with a reduced risk of dementia

by Fran Van Heuverswyn
February 9, 2026March 9, 2026

Emily Rayens, Lina S. Sy, Lei Qian, Bradley K. Ackerson, Julia Tubert, Yi Luo, Punam P. Modha, Raul O. Calderon, Elizabeth Chmielewski-Yee, Driss Oraichi, Huifeng Yun, Carol Koro & Hung Fu Tseng. Journal: Nature CommunicationsPublished: 09 February 2026DOI:… Read More »Recombinant zoster vaccine is associated with a reduced risk of dementia

Genomic epidemiology of SARS-CoV-2 in Peru from 2020 to 2024

by Fran Van Heuverswyn
January 12, 2026

Authors: Pablo Tsukayama et al. , in collaboration with UAntwerp, Global Health Institute. Abstract Background: Peru recorded one of the world’s highest COVID-19 mortality rates,… Read More »Genomic epidemiology of SARS-CoV-2 in Peru from 2020 to 2024

Challenges and opportunities in mRNA vaccine development against bacteria

by Thijs Poets
August 22, 2025August 22, 2025

Review article The global surge in antimicrobial resistance presents a critical threat to public health, emphasizing the urgent need for the development of new and… Read More »Challenges and opportunities in mRNA vaccine development against bacteria

Enterotoxigenic Escherichia coli heat-labileenterotoxin induces cell death and disruptseffector functions in porcine monocytes

by Thijs Poets
July 6, 2025July 15, 2025

This study reveals how ETEC’s heat-labile enterotoxin (LT) compromises porcine monocyte viability and immune function — providing new insights into the pathogen’s immunomodulatory strategies. Authors:Jinglin… Read More »Enterotoxigenic Escherichia coli heat-labileenterotoxin induces cell death and disruptseffector functions in porcine monocytes

T cells responses after vaccination: a regulatory perspective

by Thijs Poets
July 2, 2025July 2, 2025

This article is part of the Research Topic Community Series in Development and Harmonization of Assays and Models to Assess Immunogenicity and Correlates of Protection… Read More »T cells responses after vaccination: a regulatory perspective

The pneumococcal vaccination puzzle: one piece to solve the healthcare capacity crisis in an ageing population

by Katrien Achten
April 29, 2025April 30, 2025

About this report This white paper is an evidence-based call to action for Belgian policymakers on the prevention of pneumococcal disease in older adults and… Read More »The pneumococcal vaccination puzzle: one piece to solve the healthcare capacity crisis in an ageing population